This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Analysis of effectiveness
The analysis was based on intention-to-treat and the primary health outcomes used in the analysis being thenumber of adverse events caused by antiinfective agents, number of days of excessive antibiotic dosage, and mortality. A regression model was used to investigate the differences in costs and outcomes between strategies after controlling for differences in age, sex, severity of illness, medical service, and mortality.
Effectiveness results
Overall, 28 cases of adverse events were caused by antiinfective agents in the pre-intervention period (2 years), and 4 cases in the intervention period (1 year). The corresponding mortality figure was 22% for both periods, while the average number of days of excessive antiinfective dose was 5.9 (pre-intervention) and 2.7 (intervention), (P<0.002). After adjusting for differences in patient characteristics between groups the figures for number of days of excessive antiinfective dose changed to 5.4 (95% CI: 4.5 -6.4) in the pre-intervention period and 1.4 (95% CI: 0 -2.7) and 3.6 (95% CI: 2.0 -5.1) in the intervention period for "computer regimen followed" and "computer regiment overriden" respectively.
Clinical conclusions
The designed program showed a dramatic improvement in clinical outcomes in the management of infectious diseases.
Measure of benefits used in the economic analysis
The number of days of excessive antiinfective dosage avoided was used as the benefit measure. These were reported after adjusting for patient characteristics using a regression model.
Direct costs
Only the length of hospital and ICU stay and number of microbiology cultures were reported separately from costs. These included costs related to hospitalization and drug acquisition costs (no further details provided). The costs were reflated to 1995 figures by using the medical component of the US consumer price index. The perspective adopted in the cost analysis was not specified.
Cost results
The total cost of hospitalization was $26,315 (95% CI: 20,393 -32,237) for the intervention group patients who always received the computer regimen, $44,865 (95% CI: 38,564 -51,166) for those not always receiving the computer regimen, and $35,283 (95% CI: 31,448 -39,118) in the pre-intervention period. The p value for the comparison between the first and last figures was <0.005 (overall p<0.001).
Synthesis of costs and benefits
A synthesis was not performed since the computerized antiinfectives-management program was considered as the dominant strategy.
Authors' conclusions
A computerized antiinfectives-management program can improve the quality of patient care and reduce costs.
CRD COMMENTARY -Selection of comparators
The reason for the choice of comparator was clear.
Validity of estimate of measure of benefit
The validity of the estimate of measure of benefit might be affected by problems related to selection bias and the comparability or otherwise of the study groups (for those who were given the suggested computer regimen always and those who were not), and also, given the non-concurrent control, due to changes in practice patterns over time. Despite the fact that the authors adjusted for patient characteristics known to affect the outcomes, lack of randomization in the allocation process may have affected the validity of the results. Overall adjusted results were not presented for the intervention group.
Validity of estimate of costs
Many quantities of resource use were not reported separately from the costs. Moreover, no adequate details of the methods of cost estimation were reported. Finally, the human and physical capital costs (computer network) seem to have been omitted from the analysis.
Other issues
The conclusions reached by the authors may not be fully justified given the uncertainty in the data. The authors stated that the study findings may not be generalisable, given that the study was based on computerized medical-information systems already in operation at the institution before the intervention started. No adequate comparisons with other studies were presented. Overall, given the lack of randomisation and sensitivity analysis the results may need to be treated with some caution.
